Skip to main content
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: Nat Neurosci. 2016 Feb;19(2):206–219. doi: 10.1038/nn.4202

Table 1.

Energy homeostasis in Mc4r mutant mice

Mouse line Body weight Energy intake Energy expenditure Glucose homeostasis Autonomic outflow Other phenotypes Ref.
Mc4r−/−
Mixed background
Increased body weight from 5 weeks Hyperphagic. 46% increase in average daily consumption NR Hyperglycemic and hyperinsulinemic (more pronounced in males) NR Increased axial length.
Normal serum corticosterone levels.
16
Mc4r−/−
Mixed background
Pair-fed male mice show normal body weight.
Pair-fed female mice show intermediate body weight.
Non-pair-fed mice hyperphagic at 14 weeks of age (not at 10 weeks) Reduced basal VO2 consumption at 7 weeks (precedes obesity).
Non-pair-fed males hypolocomotive during dark cycle.
Normal basal body temperature and response to cold exposure
Non-pair-fed mice hyperglycemic and hyperinsulinemic.
Pair-fed mice normal glucose and insulin levels
Insensitive to leptin-mediated BAT Ucp1 induction NR 48
Mc4r−/−
Congenic BL/6 (3–5 generations)
Increased body weight.
Exaggerated weight gain on HCD.
Hyperphagic.
Normal body weight response to caloric restriction.
Normal feeding response to overnight fasting.
Increased consumption on high-fat diet.
Reduced basal VO2 consumption.
Reduced exergonic response to HCD.
Increased respiratory exchange ratio on HCD.
Normal basal body temperature and response to cold exposure.
Pre-obese mice are normoglycemic and normoinsulinemic.
Obese mice show hepatic insulin resistance.
Reduced exergonic response to HCD not due to reduced SNS outflow to BAT Normal body weight and feeding response to cold exposure.
Reduced circulating triglycerides.
Increased hepatic fatty acid synthesis.
47, 81, 91
Mc4r−/−
Mixed background
Increased body weight from 5 weeks Hyperphagic from weaning Pre-obese mice exhibit increased metabolic rate NR NR NR 134
Mc4r−/−
Mixed background
NR NR NR NR NR Increased circulating high- density lipoprotein 93
Mc4r−/−
Mixed obesity- resistant background
Increased body weight and adiposity from 5 weeks Hyperphagic.
Pre-obese mice responsive to anorectic effect of leptin.
NR NR Insensitive to leptin-mediated BAT Ucp1 induction NR 135
Mc4r−/−
Mixed background
Increased body weight from 5 weeks Insensitive to anorectic effects of MTII Insensitive to exergonic effects of MTII.
Hypolocomotive during the dark cycle.
NR NR NR 136
Mc4r−/−
Mixed background
NR Insensitive to anorectic effects of MTII.
Pre-obese mice responsive to anorectic effect of leptin. Obese mice unresponsive to anorectic effect of leptin.
Mice sensitive to orexigenic effects of NPY.
NR NR NR NR 137
Mc4r−/−
Mixed background (females)
NR Insensitive to anorectic effects of CCK NR NR NR NR 138
Mc4r−/−
Mixed background
NR Higher breakpoint in a progressive-ratio lever-pressing assay NR NR NR NR 50
Mc4r−/−
Mixed background
NR NR NR NR NR No antisecretory response from VIP- stimulated intestinal L-cells. Reduced PYY release. 55
Mc4r−/−
Congenic BL/6
Increased body weight from 7 weeks and increased adiposity Hyperphagic NR Hyperglycemic.
Hyperinsulinemic.
NR Obese mice normotensive, bradycardic, normal hemodynamic response to high salt diet.
Obese and pair-fed mice insensitive to hypertensive effects of leptin.
86, 139
Mc4rloxTB/loxTB
Mixed background
Increased body weight from 4 weeks Hyperphagic.
Insensitive to anorectic effects of MTII.
Reduced VO2 consumption Hyperglycemic and hyperinsulinemic from 5 weeks of age Normotensive Increased axial length 53, 82
Mc4rloxTB/loxTB NR NR NR Exaggerated fasting glucose levels and glucose intolerance during the dark cycle. Constant light conditions improves glycemia. NR NR 140
Mc4rloxTB/loxTB
Congenic 129 and mixed background
Increased body weight from 7 weeks NR NR NR NR Reduced sensitivity to Roux-en-Y gastric bypass 56
Zp3-Cre:: Mc4rloxTB/loxTB
Mixed background
Normal body weight NR NR NR NR NR 53
Nestin-Cre:: Mc4rloxTB/loxTB
Mixed background
Normal body weight NR NR NR NR Normalized axial length 53
Sim1-Cre:: Mc4rloxTB/loxTB
Mixed background
60% reduction in body weight and reduced fat and lean mass Normalized food intake. Re-sensitized to anorectic effect of MTII Reduced VO2 consumption. Hypometabolism precedes hyperphagia.
Insensitive to exergonic effects of MTII.
Mildly improved serum glucose and insulin levels at 5 weeks. Normalized glucose levels and at improved insulin levels 12 weeks Normotensive Normalized axial length 53, 67, 82
Chat-ires-Cre:: Mc4rloxTB/loxTB 10% reduction in body weight and reduced fat mass Hyperphagic Normalized VO2 consumption Mildly improved serum glucose and insulin levels. Insulin resistant. Hypertensive during dark cycle Increased axial length 69, 82
Phox2b-Cre:: Mc4rloxTB/loxTB No improvement in body weight or fat mass Hyperphagic No improvement in VO2 consumption No improvement in serum glucose levels. Normoinsulinemic and not insulin resistant NR Increased axial length 69
Sim1-Cre:: Mc4rloxTB/loxTB:: vGlut2loxP/loxP No improvement in body weight or fat mass Hyperphagic No improvement in VO2 consumption. Insensitive to exergonic effects of MTII NR NR NR 67
vGlut2-ires-Cre:: Mc4rloxTB/loxTB Normalized body weight Normalized food intake Normalized VO2 consumption Normalized serum glucose and insulin levels Normalized axial length 54
vGat-ires-Cre:: Mc4rloxTB/loxTB No improvement in body weight NR NR NR NR NR 54
Oxt-ires-Cre:: Mc4rloxTB/loxTB No improvement in body weight NR NR NR NR NR 54
Crh-ires-Cre:: Mc4rloxTB/loxTB No improvement in body weight NR NR NR NR NR 54
Pdyn-ires-Cre:: Mc4rloxTB/loxTB No improvement in body weight NR NR NR NR NR 54
Avp-ires-Cre:: Mc4rloxTB/loxTB No improvement in body weight NR NR NR NR NR 54
Drd1-cre:: Mc4rloxTB/loxTB Mild improvement in body weight and fat mass Mild improvement in hyperphagia on chow. Reduction in meal size. Partial restoration of MTII sensitivity. No improvement in VO2 consumption NR NR NR 49
Mc4rloxP/loxP Normal body weight NR NR NR NR NR 54
EIIa-Cre:: Mc4rloxP/loxP Increased body weight from 5 weeks. Increased fat and lean mass. Hyperphagic NR NR NR Increased axial length 54
Sim1-Cre:: Mc4rloxP/loxP Increased body weight from 6 weeks. Increased fat mass. Hyperphagic NR NR NR Increased axial length 54
Chat-ires-Cre:: Mc4rloxP/loxP Increased body weight from 8 weeks. 40% increase by 20 weeks. Increased fat and lean mass. Increased sensitivity to HCD. Normal feeding behavior. Hyperphagic on HCD. Reduced Ucp1 induction on HCD. Reduced energy expenditure, intermediate to Mc4rΔ/Δ.
Reduced diet-induced hypermetabolism. Normal body temperature
Hyperglycemia and hyperglucagonemia comparable to Mc4rΔ/Δ. Intermed iate hyperinsulinemia. Insulin resistant. Reduced thermogenic response to cold exposure. Reduced Ucp1 induction on cold exposure or high-calorie diet. Normal axial length 70
Phox2b-Cre:: Mc4rloxP/loxP No effect on body weight or composition. Normal sensitivity to HCD. Normal feeding behavior on HCD Normal exergonic response to a HCD Normoglycemic and normoglucagonemic. Hyperinsulinemic. Normal Ucp1 induction NR 70

Phenotypes arising from the germline and conditional genetic manipulations of mouse Mc4r expression. NR, not reported; CCK, cholecystokinin; HCD, high calorie diet.